Press releases

1 2 3 23

BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System

Jul 19, 2017

BD FACSLyric™ Flow Cytometer System with BD Multitest™ Assays Offers Reliability and Consistency

BD Transforms Microbiology Urine Testing

Jul 18, 2017

New BD Kiestra™ Urine Culture App Drives Increased Lab Efficiency and Impacts Patient Management

BD Receives FDA 510k Clearance for New Line of Customizable, 3.0mm Micro-Laparoscopic Instruments

Jun 20, 2017

New Micro-Laparoscopic Instruments Offer Surgeons Less Invasive Option for Patients

FlowJo and BD to Provide Cloud Platform for Real-Time Single-Cell Marketing Collaboration

Jun 13, 2017

Leaders in flow cytometry tools collaborate to deliver cloud data management capabilities and streamline experimental execution

BD Releases 2016 Sustainability Report

Jun 6, 2017

BD Releases 2016 Sustainability Report

BD Receives FDA 510(K) Clearance for Molecular Test for Harmful Intestinal Bacteria Causing Infectious Diarrhea

Jun 5, 2017

BD Receives FDA 510(K) Clearance for Molecular Test for Harmful Intestinal Bacteria Causing Infectious Diarrhea

BD to Present at Investor Healthcare Conferences

May 15, 2017

BD to Present at Investor Healthcare Conferences

BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Set

May 9, 2017

BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Set

BD Announces Offerings of $2.25 Billion of Common Stock and $2.25 Billion of Depositary Shares Representing Interests in Mandatory Convertible Preferred Stock

May 7, 2017

BD Announces Offerings of $2.25 Billion of Common Stock and $2.25 Billion of Depositary Shares Representing Interests in Mandatory Convertible Preferred Stock

BD Announces Commencement of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes

May 5, 2017

BD Announces Commencement of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes

1 2 3 23